Nov. 14 (UPI) -- Moderna said on Monday that its COVID-19 booster prototypes provide "superior protection" against the contagious Omicron subvariants BA.4 and BA.5.
The biotechnology company said its new vaccine boosters in Phase 2 and Phase 3 testing have triggered a "superior antibody response" compared to its original booster shots.